Elite Pharmaceuticals, Inc. Additional Paid in Capital, Common Stock
Elite Pharmaceuticals, Inc. (ELTP) had Additional Paid in Capital, Common Stock of $164.57 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2021-11-15
- 2021-09-30: Additional Paid in Capital, Common Stock $164.57M.
- 2021-06-30: Additional Paid in Capital, Common Stock $164.57M.
- 2021-03-31: Additional Paid in Capital, Common Stock $164.41M.
- 2020-12-31: Additional Paid in Capital, Common Stock $164.40M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2021-09-30 | $164.57M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $164.57M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $164.41M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $164.40M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $164.40M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $150.32M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $150.26M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $149.63M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $149.54M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $149.14M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $148.78M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $148.36M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $148.06M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $146.81M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $146.60M 10-K · filed 2019-06-21 | |
| 2017-12-31 | $145.21M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $144.92M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $144.33M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $163.90M 10-K · filed 2018-06-14 | |
| 2016-12-31 | $161.11M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $159.22M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $110.25M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $109.14M 10-K · filed 2017-06-14 | |
| 2015-12-31 | $90.28M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $113.53M 10-Q · filed 2015-12-30 | $116.20M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $116.66M 10-Q · filed 2015-12-30 | $164.32M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $106.93M 10-K · filed 2016-06-15 | $161.02M 10-K · filed 2015-06-15 |
| 2014-12-31 | $156.17M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $152.38M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $144.70M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $143.56M 10-K · filed 2015-06-15 | |
| 2013-12-31 | $133.08M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $131.11M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $121.02M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $119.69M 10-K · filed 2014-06-30 | |
| 2012-12-31 | $117.63M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $117.55M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $117.04M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $114.91M 10-K · filed 2013-06-21 | |
| 2011-12-31 | $108.65M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $108.04M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $106.82M 10-Q/A · filed 2011-08-19 | |
| 2011-03-31 | $97.12M 10-K · filed 2012-06-29 |